NLRP3 and diabetes mellitus: NLRP3 inflammasome, IL-1β, and IL-18 can affect blood glucose control and insulin resistance, which are related to the pathogenesis of diabetes (23, 24), and play an important role in diabetes-induced systemic chronic inflammation and insulin signal transduction (15, 25).